The Association between ADHD and the Severity of COVID-19 Infection.


Journal

Journal of attention disorders
ISSN: 1557-1246
Titre abrégé: J Atten Disord
Pays: United States
ID NLM: 9615686

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 3 4 2021
medline: 29 1 2022
entrez: 2 4 2021
Statut: ppublish

Résumé

Patients with ADHD are at increased risk of acquiring COVID-19. The present study assessed the possibility that ADHD also increases the risk of severe COVID-19 infection. We assessed 1,870 COVID-19 positive patients, aged 5 to 60 years, registered in the database of Leumit Health Services (LHS, Israel), February to -June 2020, of whom 231 with ADHD. Logistic regression analysis models evaluated the association between ADHD and the dependent variables of being symptomatic/referral to hospitalization, controlling for demographic and medical variables. Age, male sex, and BMI were confirmed to be significant risk factors for increased COVID-19 severity. ADHD was found to be associated with increased severity of COVID-19 symptoms ( ADHD is associated with poorer outcomes in COVID-19 infection.

Identifiants

pubmed: 33797281
doi: 10.1177/10870547211003659
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

491-501

Auteurs

Eugene Merzon (E)

Leumit HMO, Tel-Aviv, Israel.
Tel Aviv University, Israel.

Margaret D Weiss (MD)

Cambridge Health Alliance, MA, USA.

Samuele Cortese (S)

Center for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.
Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK.
Solent NHS Trust, Southampton, UK.
Hassenfeld Children's Hospital at NYU Langone, New York University Child Study Center, New York City, New York, USA.
Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK.

Ann Rotem (A)

ADHD Unit, Geha Mental Health Center, Petah Tikva, Israel.

Tzipporah Schneider (T)

Clalit Health Services, Bnei Brak, Israel.

Stephanie G Craig (SG)

York University, Toronto, Ontario, Canada.

Shlomo Vinker (S)

Leumit HMO, Tel-Aviv, Israel.
Tel Aviv University, Israel.

Avivit Golan Cohen (A)

Leumit HMO, Tel-Aviv, Israel.
Tel Aviv University, Israel.

Ilan Green (I)

Leumit HMO, Tel-Aviv, Israel.
Tel Aviv University, Israel.

Shai Ashkenazi (S)

Ariel University, Israel.

Abraham Weizman (A)

Tel Aviv University, Israel.
ADHD Unit, Geha Mental Health Center, Petah Tikva, Israel.

Iris Manor (I)

Tel Aviv University, Israel.
ADHD Unit, Geha Mental Health Center, Petah Tikva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH